Patterns of progression in patients treated with nivolumab plus ipilimumab (NIVO plus IPI) versus sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214 Meeting Abstract
| Authors: | Tannir, N. M.; Motzer, R. J.; Albiges, L.; Plimack, E. R.; George, S.; Powles, T.; Donskov, F.; Rini, B. I.; Grunwald, V.; Hammers, H. J.; Choueiri, T. K.; Gurney, H.; Tykodi, S. S.; Porta, C.; Burotto, M.; Tomita, Y.; Lee, C. W.; Tang, C.; McDermott, D. F.; McKay, R. R. |
| Abstract Title: | Patterns of progression in patients treated with nivolumab plus ipilimumab (NIVO plus IPI) versus sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214 |
| Meeting Title: | 2021 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2021 Feb 11-13 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-02-20 |
| Language: | English |
| ACCESSION: | WOS:000636801500328 |
| DOI: | 10.1200/JCO.2021.39.6_suppl.313 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 313 -- Source: Wos |
